Login
Toggle sidebar

Lint: temozolomide

temozolomide
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Mechanism of action"

Line 2:1 · "Mechanism of action" is not a recognised heading for this article type.

"Resistance to temozolomide"

Line 4:1 · "Resistance to temozolomide" is not a recognised heading for this article type.

"Temozolomide-induced hypermutation"

Line 7:1 · "Temozolomide-induced hypermutation" is not a recognised heading for this article type.
Oxford Comma
suggestion

"Temozolomide is an oral chemotherapeutic drug primarily used in the treatment of astrocytomas, oligodendrogliomas and glioblastomas, often in conjunction with radiotherapy (Stupp protocol)."

Line 1:102 · Use the Oxford comma in 'astrocytomas, oligodendrogliomas and glioblastomas'.
Links
0
0
0
0
0
0
0
0
0